SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvi Japan Oppo. Regulatory News (AJOT)

Share Price Information for Avi Japan Oppo. (AJOT)

Share Price is delayed by 15 minutes
Get Live Data
164.00    2.50 (1.55%)
Bid:
162.50
Ask:
163.50
Spread: 1.00 (0.615%)
Market Cap: £364.73m
AJOT Live PriceLast checked at - London Stock Exchange

Intraday Avi Japan Oppo. Share Chart

Overview note from QuotedData

10 Jun 2026 16:50

RNS Number : 8294H
AVI Japan Opportunity Trust PLC
10 June 2026
 

 

AVI Japan Opportunity - Overview note from QuotedData

10 June 2026

Primed to perform?

AVI Japan Opportunity Trust (AJOT) has made good use of the extra resources gained from its merger with Fidelity Japan. The trust holds large positions in undervalued and overcapitalised companies, aiming to unlock their hidden value.

More companies are now open to working with AJOT, so much of this progress happens privately. As AGM season continues, AJOT's manager has submitted several proposals that could help drive further NAV growth for the trust.

Full Research:

https://quoteddata.com/research/avi-japan-opportunity-primed-to-perform-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note AVI Japan Opportunity Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEASKEFLNKEFA
Date   Source Headline
15th Apr 202611:10 amRNSNet Asset Value(s)
14th Apr 202612:24 pmRNSNet Asset Value(s)
13th Apr 202612:49 pmRNSNet Asset Value(s)
10th Apr 202611:10 amRNSNet Asset Value(s)
9th Apr 20261:07 pmRNSNet Asset Value(s)
8th Apr 20262:04 pmRNSNet Asset Value(s)
7th Apr 20265:34 pmRNSTransaction in Own Shares
7th Apr 20261:24 pmRNSNet Asset Value(s)
1st Apr 20265:38 pmRNSTransaction in Own Shares
1st Apr 20264:04 pmRNSNet Asset Value(s)
1st Apr 202610:09 amRNSTotal Voting Rights
31st Mar 20263:55 pmRNSNet Asset Value(s)
30th Mar 20262:00 pmRNSNet Asset Value(s)
27th Mar 20261:10 pmRNSNet Asset Value(s)
26th Mar 202612:06 pmRNSNet Asset Value(s)
25th Mar 202612:15 pmRNSNet Asset Value(s)
24th Mar 202612:19 pmRNSNet Asset Value(s)
23rd Mar 202611:43 amRNSNet Asset Value(s)
20th Mar 202610:12 amRNSNet Asset Value(s)
19th Mar 202612:24 pmRNSNet Asset Value(s)
18th Mar 202611:23 amRNSNet Asset Value(s)
17th Mar 20266:21 pmRNSHolding(s) in Company - Replacement
17th Mar 20265:35 pmRNSIssue of Equity
17th Mar 20262:23 pmRNSNet Asset Value(s)
17th Mar 202610:02 amRNSHolding(s) in Company
17th Mar 20269:56 amRNSIssue of Equity
16th Mar 20266:09 pmRNSIssue of Equity
16th Mar 20262:24 pmRNSInvestment Manager Increases Holding
16th Mar 20262:24 pmRNSInvestment Manager Increases Holding
16th Mar 20261:37 pmRNSNet Asset Value(s)
13th Mar 20265:46 pmRNSIssue of Equity
13th Mar 20267:00 amRNSAnnual Financial Report
13th Mar 20267:00 amRNSAnnual Financial Report
11th Mar 202611:56 amRNSNet Asset Value(s)
10th Mar 202612:43 pmRNSNet Asset Value(s)
9th Mar 202611:45 amRNSNet Asset Value(s)
9th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
6th Mar 20261:14 pmRNSNet Asset Value(s)
5th Mar 202611:29 amRNSNet Asset Value(s)
4th Mar 20265:27 pmRNSIssue of Equity
4th Mar 202612:39 pmRNSNet Asset Value(s)
3rd Mar 202612:07 pmRNSNet Asset Value(s)
2nd Mar 20265:02 pmRNSHolding(s) in Company
2nd Mar 202612:31 pmRNSTotal Voting Rights
2nd Mar 202611:35 amRNSNet Asset Value(s)
2nd Mar 202611:03 amRNSAppointment of Joint Corporate Broker
27th Feb 20261:08 pmRNSNet Asset Value(s)
26th Feb 20265:19 pmRNSIssue of Equity
26th Feb 20261:04 pmRNSNet Asset Value(s)
25th Feb 202612:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.